Cannabis short sellers saw hefty gains of over US$250 million after producer Tilray (NASDAQ:TLRY) reported striking losses in its most recent quarterly report and saw a share price drop.

According to a new report by Ihor Dusaniwsky, managing director of predictive analytics at S3 Partners, a short seller financial data and analytics firm, marijuana short sellers have faced challenges this year.

Before Wednesday’s (August 14) trading session, short sellers in the space had taken losses of US$951 million over a year-to-date period in the 20 top shorted cannabis stocks.

“Today these short sellers have recouped their August losses, up US$269.1 million in daily mark-to-market profits and now up US$11.7 million for the month of August, but still down -US$681.9 million year-to-date 2019,” the report states.

So far in 2019, the short interest in the cannabis market is up US$2.28 billion, the S3 Partners report indicates. The market action now carries an average borrow fee of 17.7 percent.

“Short selling is fairly concentrated to a handful of names, with the top 20 shorts making up over 85 (percent) of the total shorting executed in the sector,” Dusaniwsky wrote in the report.

On Wednesday, shares of Tilray dropped 15.17 percent in value to a closing price of US$39.04. During after-hours trading, the company was down an additional 0.1 percent.

The cannabis company, which is valued at US$3.8 billion, took in the drop after reporting a net loss of US$35.1 million for Q2 despite producing revenue of US$45.9 million.

“We are pleased with our second quarter results and strong business momentum,” Brendan Kennedy, Tilray’s president and CEO, said in a press release. “As we continue to grow, we remain focused on our long-term strategic objectives and deploying capital to maximize stockholder value.”

Overall, the marijuana sector is facing a decline as global markets react to losses on the Dow Jones Industrial Average (INDEXDJX:.DJI) seen on Wednesday due to a warning signal from the bond market resembling predictions for a recession.

S3 Partners projects a potential short squeeze for the cannabis space due to short seller activity.

A short squeeze takes place when a stock that’s been heavily shorted moves upward in value, causing short sellers to close their short position.

“With high financing costs, lack of liquidity in the stock borrow market and year-to-date losses the threat of a short squeeze hovers over many stocks in the sector,” the report explains.

“If these Cannabis stocks can reverse today’s price weakness with positive earnings results from stocks like Canopy Growth (NYSE:CGC,TSX:WEED), a follow-on sector wide rally may shake some shorts out of their positions and squeeze stock prices even higher.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less